logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
O

Ola Landgren

Sylvester Comprehensive Cancer Center

102H-index
1.4KPaper Count
4.3WCitation Count
Published Papers 249
Publication Date
logo
Redefining light-chain smoldering multiple myeloma: prevalence and progression risk
errLeukemia
IF13.4
err2026-07-06
err0
errOAAI
errCecilie Velsoe Maeng; Sigrún Thorsteinsdóttir; Jón Þórir Óskarsson; Sæmundur Rögnvaldsson; Thórir Einarsson Long; Christian Brieghel; Morten Nørgaard Andersen; Andri Ólafsson; Ásdís R. Þórðardóttir; Brynjar Viðarsson; Páll T. Önundarson; Bjarni A. Agnarsson; Margrét Sigurðardóttir; Ingunn Þorsteinsdóttir; Ísleifur Ólafsson; Elías Eyþórsson; Ásbjörn Jónsson; Stephen Harding; Ola Landgren; Thorvardur Jon Love; Kirsten Grønbæk; Carsten U. Niemann; Sigurður Y. Kristinsson
errShare
errSave
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10–49 years of age: a population-based study from the National Health and Nutritional Examination Survey
errBlood Cancer Journal
IF11.6
err2026-05-25
err0
errOAAI
errShaji Kumar; David Murray; Dirk R. Larson; Ola Landgren; P. Leif Bergsagel; James R. Cerhan; S. Vincent Rajkumar
errShare
errSave
Minimal residual disease testing in hematologic malignancies: From early endpoint to precision clinical decision making
errSeminars in Hematology
IF4.1
err2026-05-14
err0
PREAI
errOla Landgren
errShare
errSave
MGUS prevalence among active-duty military personnel
errBlood Cancer Journal
IF11.6
err2026-05-07
err0
errOAAI
errDickran Kazandjian; Christin DeStefano; Sarah Darmon; Alexander Dew; Elizabeth Hill; Katie Thoren; Ola Landgren
errShare
errSave
Smoldering multiple myeloma in transition: redefining early myeloma in the modern era
errLeukemia
IF13.4
err2026-05-01
err0
errOAAI
errLandgren, Ola
errShare
errSave
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study
errBlood Cancer Journal
IF11.6
err2026-04-11
err0
errOAAI
errRobert Palmason; Elias Eythorsson; Sæmundur Rögnvaldsson; Sigrún Thorsteinsdóttir; Sara Ekberg; Michael Crowther; Elin Ruth Reed; Jon Þórir Oskarsson; Gudrun Asta Sigurdardottir; Thor Aspelund; Brynjar Vidarsson; Pall Torfi Onundarson; Bjarni Agnar Agnarsson; Margret Sigurdardottir; Ingunn Thorsteinsdottir; Signy Vala Sveinsdottir; Isleifur Olafsson; Asdis Rosa Thordardottir; Asbjorn Jonsson; Olafur S. Indridason; Gauti Gislason; Andri Olafsson; Jon Kristinn Sigurdsson; Hlif Steingrimsdottir; Thorir Einarsson Long; Malin Hultcrantz; Brian G. M. Durie; Stephen Harding; Ola Landgren; Runolfur Palsson; Thorvardur Jon Love; Sigurdur Yngvi Kristinsson
errShare
errSave
Excess Risk of Monoclonal Gammopathy in Patients With Gaucher Disease
errAmerican Journal of Hematology
IF9.9
err2026-02-18
err0
errOAAI
errMajdolen Istaiti; Katie Thoren; Dickran Kazandjian; Ari Zimran; Dafna Frydman; Tama Dinur; Michal Becker-Cohen; Shoshana Revel-Vilk; Ola Landgren
errShare
errSave
MRD in multiple myeloma: from an early endpoint for accelerated approval to MRD driven treatment and clinical management
errSeminars in Hematology
IF4.1
err2026-01-29
err0
PREAI
errOla Landgren; Rafat Abonour; Dickran Kazandjian
errShare
errSave
Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH)
errBlood
IF23.1
err2026-01-07
err0
errOAAI
errMarcella Kaddoura; J. Erin Wiedmeier-Nutor; Vikas A. Gupta; Tomas Jelinek; Bachisio Ziccheddu; Suganti Shivaram; Hongwei Tang; Rebecca W. Owens; Tereza Sevcikova; Rodrigo Fonseca; Michael Durante; Benjamin Diamond; Logan Zhao; Yuan X Zhu; Chang-Xin Shi; Shannon M Matulis; Constantine S Mitsiades; Ola Landgren; Saad Usmani; Roman Hajek
errShare
errSave
Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controls
errPLOS ONE
IF2.6
err2025-10-27
err0
PREAI
errCoffey, David G.; Zhang, Yong; Hill, Elizabeth; Cross, Frank; Philip, Reena; Theoret, Marc R.; Landgren, Ola; Baines, Andrea C.; Kazandjian, Dickran; Wu, Jian
errShare
errSave
Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma
errHemaSphere
IF14.6
err2025-09-23
err0
PREAI
errJuan-Jose Garces; Benjamin Diamond; Tereza Sevcikova; Serafim Nenarokov; Daniel Bilek; Eva Radova; Ondrej Venglar; Veronika Kapustova; Ross Firestone; Kylee Maclachlan; Anish Simhal; Lucie Broskevicova; Jan Vrana; Ludmila Muronova; Tereza Popkova; Jana Mihalyova; Hana Plonkova; Michael Durante; Bachisio Ziccheddu; Michal Simicek; Hearn Jay Cho; George Mulligan; Jonathan Keats; David Zihala; Ola Landgren; Roman Hajek; Saad Usmani; Francesco Maura; Tomas Jelinek
errShare
errSave
Increased risk of infections in smoldering multiple myeloma: results from the screened iStopMM study
errLeukemia
IF13.4
err2025-09-12
err0
errOAAI
errLærke Sloth Andersen; Ricardo Berenguer Navarro; Sara Ekberg; Sæmundur Rögnvaldsson; Marína Rós Levy; Ingigerður Sólveig Sverrisdóttir; Brynjar Viðarsson; Páll Torfi Önundarson; Bjarni A. Agnarsson; Margrét Sigurðardóttir; Ingunn Þorsteinsdóttir; Ísleifur Ólafsson; Ásdís Rósa Þórðardóttir; Elías Eyþórsson; Ásbjörn Jónsson; Andri Ólafsson; Brian G. M. Durie; Stephen Harding; Ola Landgren; Thorvardur Jón Löve; Sigurður Yngvi Kristinsson; Sigrún Thorsteinsdóttir
errShare
errSave
Temporal genomic dynamics shape clinical trajectory in multiple myeloma
errNature Genetics
IF0
err2025-08-20
err0
errOAAI
errFrancesco Maura; Marcella Kaddoura; Alexandra M. Poos; Linda B. Baughn; Bachisio Ziccheddu; Marc-Andrea Bärtsch; Anthony Cirrincione; Kylee Maclachlan; Monika Chojnacka; Benjamin Diamond; Marios Papadimitriou; Patrick Blaney; Lukas John; Philipp Reichert; Stefanie Huhn; Dylan Gagler; Yanming Zhang; Ahmet Dogan; Alexander M. Lesokhin; Faith Davies; Hartmut Goldschmidt; Roland Fenk; Katja C. Weisel; Elias K. Mai; Neha Korde; Gareth J. Morgan; S. Vincent Rajkumar; Shaji Kumar; Saad Usmani; Ola Landgren; Marc S. Raab; Niels Weinhold
errShare
errSave
Current and future role of carfilzomib-based quadruplet combinations as therapy for newly diagnosed multiple myeloma
errHemaSphere
IF14.6
err2025-07-16
err0
errOAAI
errOla Landgren; Noa Biran; Elizabeth K. O'Donnell; Joseph Mikhael; Katja C. Weisel; Annemiek Broijl; Saad Z. Usmani; Philippe Moreau; Francesca M. Gay
errShare
errSave
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific Antibodies
errBlood Advances
IF7.1
err2025-07-03
err0
errOAAI
errAndrew Kowalski; Jill Lykon; Benjamin Diamond; David Coffey; Marcella Kaddoura; Francesco Maura; James Hoffman; Abhishek Pandey; Dickran Kazandjian; Ola Landgren
errShare
errSave
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
errBlood
IF23.1
err2025-06-16
err0
PREAI
errBenjamin Diamond; Linda Baughn; Mansour Poorebrahim; Alexandra M. Poos; Holly Lee; Marcella Kaddoura; J. Erin Wiedmeier-Nutor; Michael Durante; Gregory Otteson; Dragan Jevremovic; Hongwei Tang; Stefan Fröhling; Marc A. Baertsch; Marios Papadimitriou; Bachisio Ziccheddu; Tomas Jelinek; Cendrine Lemoine; Alexey Rak; Damian J. Green; Ola Landgren; Paola Neri; Leif Bergsagel; Esteban Braggio; Shaji Kumar; Marc S. Raab; Rafael Fonseca; Nizar Bahlis; Niels Weinhold; Francesco Maura
errShare
errSave
Long-Term Cancer Risk of US Service Members Exposed to Burn Pits in Iraq
errJAMA NETWORK OPEN
IF9.7
err2025-04-10
err0
errOAAI
errRobertson, Ian; Sgrignoli, Robert; Dew, Alexander; Darmon, Sarah; Landgren, Ola; Kazandjian, Dickran
errShare
errSave
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carflzomib and antiCD38 monoclonal antibodies (Jan, 10.1007/s00277-024-06143-7, 2025)
errANNALS OF HEMATOLOGY
IF2.4
err2025-03-01
err0
errOAAI
errCosta, Luciano J.; Gay, Francesca; Landgren, Ola; Mateos, Maria-Victoria; Moreau, Philippe; Touzeau, Cyrille; Ertel, Franziska; McFadden, Ian; Najdi, Rani; Weisel, Katja
errShare
errSave
Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma Treated With Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: An Analysis of Patient-Reported Outcomes From the Phase 3 CANDOR Trial
errclinical lymphoma myeloma leukemia
IF0
err2025-02-19
err0
PREAI
errKatja Weisel; Maria-Victoria Mateos; Ola Landgren; Xavier Leleu; Hang Quach; Lee Bennett; Mihaela Talpes; Istvan Majer; Sachin Patel; Saad Z. Usmani
errShare
errSave
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclax
errBLOOD CANCER JOURNAL
IF11.6
err2025-02-02
err0
errOAAI
errCoughlin, Caroline A.; Chahar, Dhanvantri; Lekakis, Marianna; Youssfi, Abdessamad A.; Li, Lingxiao; Roberts, Evan; Gallego, Natalia Campos; Volmar, Claude-Henry; Landgren, Ola; Brothers, Shaun; Griswold, Anthony J.; Amador, Catalina; Bilbao, Daniel; Maura, Francesco; Schatz, Jonathan H.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
M
Mark J. Daly
H-index: 224 · Papers: 1.2K
V
Vilmundur Guðnason
H-index: 189 · Papers: 1.4K
E
Elı́as Campo
H-index: 173 · Papers: 1.6K
S
S. Vincent Rajkumar
H-index: 165 · Papers: 1.9K
R
Robert A. Kyle
H-index: 164 · Papers: 1.9K
View more